RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Cancer Biomarkers: Players, products and prospects (Volume I)
Aug 2008 - 138 pages - $1,040
Eli Lilly Drops Plans to Seek Approval For its Established Drug Alimta as a Treatment For Head And Neck Cancer
Nov 2010 - 5 pages - $500
Nasopharyngeal Cancer - Pipeline Review, Q1 2011
Jan 2011 - 22 pages - $500
Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
Oct 2010 - 64 pages - $2,000
Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
Sep 2010 - 78 pages - $3,500
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
Methotrexate (Head and Neck Cancer) - Analysis and Forecasts to 2020
Oct 2011 - 43 pages - $2,000
Nasopharyngeal Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 42 pages - $1,000
Bleomycin (Head and Neck Cancer) –Analysis and Forecasts to 2020
Oct 2011 - 43 pages - $2,000
CNS Biomarkers: Players, products and prospects (Volume II)
Aug 2008 - 110 pages - $1,040
More Related Market Research Reports >>>

Your selection

Industry sector
Research tools del
Biomarkers del
Therapeutic target
Oncology del
Head and neck cancer del
Nasopharyngeal cancer del
Year
2001 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us